We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Immunologic Testing for COVID-19

White Paper   Feb 24, 2021

Immunologic Testing for COVID-19
 
VIEW WHITE PAPER
 
 
Advertisement
 

Related White Papers

Rapid Implementation of Novel Affinity Purification

White Paper

The rapid and cost-effective production of conventional monoclonal antibodies (mAbs) for clinical trials has contributed toward their wide adoption. As the number of next-generation antibody-based candidates with modified or absent Fc domains increases, biomanufacturers face a need to establish alternative affinity purification technologies.

READ MORE

Improving Aggregate Removal To Enhance Clinical Manufacturing of mAbs

White Paper

Over the past two decades, monoclonal antibodies (mAbs) have been one of the most dominant segments of the biotherapeutics market. Ensuring mAbs’ safety and efficacy is vital but is made complicated by the fact that antibodies can have a tendency to aggregate during production, decreasing efficacy and increasing the risk of immunogenicity.

READ MORE

Affinity Tags Head Toward the Vaccination Clinic

White Paper

Protein purification can be a challenging process. Since proteins are expressed in biological systems such as cells, the protein must be purified from a complex mixture. Generic column-based purification procedures exploiting differences in protein size and charge, tend to give imperfect results.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE